Meg specialises in US corporate and securities law, advising on, among other things, general corporate matters and venture capital financing transactions, particularly in the life sciences sector.
Meg's day-to-day work focuses on advising life sciences and technology companies at all stages of development, with a particular focus on advising both companies and investors in venture capital financing transactions, from early-stage to late-stage. She also works closely with entrepreneurs to counsel them through initial company formation issues, day-to-day corporate governance matters, and liquidity events.
Prior to joining Taylor Wessing, she spent ten years at a top-tier firm in California, where she represented prominent US and international companies and funds in life sciences and technology financing transactions and exits. She is a current member of the California Bar.
Meg particularly enjoys advising clients on complex US and cross-border venture financing transactions.
Represented client utilizing a generated AI discovery platform in oversubscribed financing round with multiple strategic and institutional investors
Represented U.S. medical imaging software and device company in late-stage financing round
von mehreren Autoren
Advising Waivgen on its acquisition by Synechron
von mehreren Autoren
Advising Artificial Societies on Pre-Seed and Seed funding rounds
von mehreren Autoren
von Dr. Jens Wolf und Philipp Hoegl
von mehreren Autoren
von Dr. Daniel Tietjen und Daniel Dietrich
von Dr. Amir-Said Ghassabeh und Stephan Manuel Nagel, LL.M. (EUI)
von Dr. Ernst-Albrecht von Beauvais, LL.M. (Berkeley) und Daniel Mursa, LL.M. (Köln/Paris I)
von Daniel Dietrich und Dr. Daniel Tietjen
von Dr. Daniel Tietjen und Daniel Dietrich